These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17613896)

  • 1. Development of an omeprazole parenteral formulation with hydroxypropyl-beta-cyclodextrin.
    Holvoet C; Heyden YV; Plaizier-Vercammen J
    Pharm Dev Technol; 2007; 12(3):327-36. PubMed ID: 17613896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use.
    Holvoet C; Heyden YV; Plaizier-Vercammen J
    Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in-vitro release rate of fentanyl-cyclodextrin complexes for prolonged action in epidural analgesia.
    Holvoet C; Plaizier-Vercammen J; Vander Heyden Y; Gabriëls M; Camu F
    Int J Pharm; 2003 Oct; 265(1-2):13-26. PubMed ID: 14522114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
    Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
    Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-hydroxypropyl-beta-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid.
    Lin HS; Chean CS; Ng YY; Chan SY; Ho PC
    J Clin Pharm Ther; 2000 Aug; 25(4):265-9. PubMed ID: 10971776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Wang S; Ding Y; Yao Y
    Drug Dev Ind Pharm; 2009 Jul; 35(7):808-13. PubMed ID: 19337873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-beta-cyclodextrin.
    Gladys G; Claudia G; Marcela L
    Eur J Pharm Sci; 2003 Nov; 20(3):285-93. PubMed ID: 14592694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs.
    Wu WM; Wu J; Bodor N
    Pharmazie; 2002 Feb; 57(2):130-4. PubMed ID: 11878189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.
    Suihko E; Korhonen O; Järvinen T; Ketolainen J; Jarho P; Laine E; Paronen P
    Int J Pharm; 2001 Mar; 215(1-2):137-45. PubMed ID: 11250099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New injectable melphalan formulations utilizing (SBE)(7m)-beta-CD or HP-beta-CD.
    Ma DQ; Rajewski RA; Stella VJ
    Int J Pharm; 1999 Nov; 189(2):227-34. PubMed ID: 10536251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of formulation technique for hydroxypropyl-beta-cyclodextrin on the stability of aspirin in HFA 134a.
    Williams RO; Liu J
    Eur J Pharm Biopharm; 1999 Mar; 47(2):145-52. PubMed ID: 10234539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxypropyl-beta-cyclodextrin increases aqueous solubility and stability of anandamide.
    Jarho P; Urtti A; Järvinen K; Pate DW; Järvinen T
    Life Sci; 1996; 58(10):PL 181-5. PubMed ID: 8602110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New injectable aqueous carbamazepine solution through complexing with 2-hydroxypropyl-beta-cyclodextrin: tolerability and pharmacokinetics after intravenous injection in comparison to a glycofurol-based formulation.
    Löscher W; Hönack D; Richter A; Schulz HU; Schürer M; Düsing R; Brewster ME
    Epilepsia; 1995 Mar; 36(3):255-61. PubMed ID: 7614909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
    Liu M; Cao W; Sun Y; He Z
    Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
    Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin derivatives in pharmaceutics.
    Albers E; Müller BW
    Crit Rev Ther Drug Carrier Syst; 1995; 12(4):311-37. PubMed ID: 9501966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.